Showing 1 - 10 of 70
Background:Background: The credibility of contingent valuation studies has been questioned because of the potential occurrence of scope insensitivity, i.e. that respondents do not react to higher quantities or qualities of a good. Abstract: Objective:Objective: The aim of this study was to...
Persistent link: https://www.econbiz.de/10011005065
Background:Background: National EQ-5D value sets are developed because preferences for health may vary in different populations. UK values are lower than US values for most of the 243 possible EQ-5D health states. Although similar protocols were used for data collection, analytic choices...
Persistent link: https://www.econbiz.de/10011005072
Persistent link: https://www.econbiz.de/10008690226
Background:Background: Chronic obstructive pulmonary disease (COPD) is currently the fourth leading cause of death worldwide. It has serious health effects and causes substantial costs for society. Abstract: Objectives:Objectives: The aim of the present paper was to develop a state-of-the-art...
Persistent link: https://www.econbiz.de/10010561838
Background:Background: Cost data in healthcare are often skewed across patients. Thus, researchers have used either a log transformation of the dependent variable or generalized linear models with log links. However, frequently these non-linear approaches produce non-linear incremental effects:...
Persistent link: https://www.econbiz.de/10010567011
Persistent link: https://www.econbiz.de/10010567013
Background:Background: Economic factors are a limiting factor toward the implementation of many health programmes and interventions. Economic evaluation has a great potential to contribute toward cost-effective healthcare delivery in South Africa. Little is known about the characteristics and...
Persistent link: https://www.econbiz.de/10010569826
The debate surrounding whether the findings of efficacy studies are applicable to real-world treatment situations is ongoing. The issue of lack of applicability due to a lack of clinical heterogeneity could be addressed by employing less restrictive inclusion criteria. Given that health economic...
Persistent link: https://www.econbiz.de/10010614269
To test the effect of differences in acquisition cost and budget-based monetary compensation systems on the intent to support the adoption of a cost-effective new drug, over 350 hospital pharmacy directors were asked to indicate their intentions as to the adoption of a cost-effective new...
Persistent link: https://www.econbiz.de/10005007612
Persistent link: https://www.econbiz.de/10008506284